| 英文别名： |
Imatinib Mesylate;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;CGP-57148B;GLEEVEC;GLIVEC;IMATINIB METHANESULFONATE;STI-571;IMATINIB BASE(IMA-3);Imatinib Methanesulfonate, STI-571, CGP-57148B, Glivec;IMATINIB MESYLATE (IMATINIB METHANESULFONATE);alpha-IMATINIB MESYLATE;Imatinib mesylate(TINIBS );Imatinib Mesylate (STI571);4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]benzamide methanesulfonic aci...;4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]benzamide methanesulfonic acid salt;Gleevec (Imatinib Mesylate);Imatinib;Imatinib (mesylate);Imatinib Mesilate;Imatinib Mesylate (Imatinib Methanesulfonate,Gleevec®,Glivec® );Imatinnib Mesylate;matinib mesylate;Gleevac;Imantinib mesylate;Imatinib mesylate;4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate;4-[(4-Methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide mesylate;CGP 57148;Genfatinib;imatinib monomesylate;CGP 57148B;Imatinib, methanesulfonate salt;8A1O1M485B;STI 571;Imatinib mesylate, 98%;Imatinib mesylate (USAN);Imatinib mes;Imatinib mesylate [USAN];DSSTox_RID_79501;DSSTox_CID_20502;DS;STI571 Mesylate;CGP-57148B Mesylate;Imatinib mesylate?;Q-201232;sti-571;220127-57-1;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate;;4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;CHEMBL1642;HMS3394B09;MFCD04307699;QTI571;BCPP000204;HMS3372O12;I0936;Imatinib medac;IMATINIB MESYLATE [VANDF];Glivec (TN);IMATINIB MESILATE (EP MONOGRAPH);BENZAMIDE, 4-((4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINOPHENYL)-, METHANESULFONATE SALT;HMS3265E01;EX-A954;EX-A954;J-523068;J-523068;Imatinib monomethanesulfonate;Imatinib methane sulfonate;Imatinib monomethanesulfonate;D01441;Imatinib methane sulfonate;220127-57-1 (mesylate);D01441;SCHEMBL8217;220127-57-1 (mesylate);4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide methanesulfonate;SCHEMBL8217;MLS001401456;4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide methanesulfonate;IMATINIB MESILATE [WHO-DD];MLS001401456;HMS2233D16;IMATINIB MESILATE [WHO-DD];GGP-57148B;HMS2233D16;QTI-571;N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1... |
沪公网安备31011402010658号 
